Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 28 | 2025 | 361 | 6.320 |
Why?
|
| Nucleus Accumbens | 12 | 2023 | 47 | 3.590 |
Why?
|
| Fentanyl | 5 | 2026 | 66 | 3.430 |
Why?
|
| Analgesics, Opioid | 12 | 2026 | 526 | 3.010 |
Why?
|
| Sleep | 6 | 2026 | 240 | 2.780 |
Why?
|
| Sex Characteristics | 11 | 2026 | 211 | 2.550 |
Why?
|
| Substance Withdrawal Syndrome | 5 | 2025 | 126 | 2.350 |
Why?
|
| Opioid-Related Disorders | 5 | 2025 | 526 | 1.930 |
Why?
|
| Cocaine | 8 | 2023 | 101 | 1.760 |
Why?
|
| Sleep Wake Disorders | 4 | 2025 | 77 | 1.490 |
Why?
|
| Mice, Inbred C57BL | 17 | 2026 | 3468 | 1.350 |
Why?
|
| Wakefulness | 3 | 2026 | 43 | 1.320 |
Why?
|
| Substance-Related Disorders | 6 | 2024 | 750 | 1.200 |
Why?
|
| Animals | 49 | 2026 | 21287 | 1.170 |
Why?
|
| Ethanol | 9 | 2020 | 329 | 1.150 |
Why?
|
| Mice | 33 | 2026 | 11086 | 1.140 |
Why?
|
| Reward | 8 | 2022 | 89 | 1.050 |
Why?
|
| Corpus Striatum | 5 | 2025 | 98 | 1.050 |
Why?
|
| Neonatal Abstinence Syndrome | 2 | 2025 | 42 | 1.010 |
Why?
|
| Prefrontal Cortex | 6 | 2026 | 127 | 0.990 |
Why?
|
| Killer Cells, Natural | 3 | 2013 | 219 | 0.970 |
Why?
|
| Period Circadian Proteins | 3 | 2015 | 68 | 0.910 |
Why?
|
| Motor Activity | 7 | 2015 | 343 | 0.900 |
Why?
|
| Brain | 9 | 2026 | 1600 | 0.900 |
Why?
|
| Glycerides | 1 | 2024 | 11 | 0.850 |
Why?
|
| Arachidonic Acids | 1 | 2024 | 27 | 0.840 |
Why?
|
| Endocannabinoids | 1 | 2024 | 23 | 0.840 |
Why?
|
| Circadian Clocks | 3 | 2017 | 44 | 0.800 |
Why?
|
| Chronobiology Disorders | 2 | 2014 | 4 | 0.790 |
Why?
|
| Stress, Psychological | 2 | 2019 | 475 | 0.770 |
Why?
|
| Alcohol Drinking | 6 | 2018 | 322 | 0.740 |
Why?
|
| Male | 41 | 2026 | 30942 | 0.740 |
Why?
|
| Hormones | 2 | 2021 | 62 | 0.740 |
Why?
|
| Analgesia | 1 | 2022 | 36 | 0.720 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2020 | 160 | 0.700 |
Why?
|
| Valproic Acid | 1 | 2020 | 24 | 0.660 |
Why?
|
| Neurons | 7 | 2026 | 933 | 0.640 |
Why?
|
| Nerve Tissue Proteins | 6 | 2022 | 428 | 0.630 |
Why?
|
| Sirtuin 1 | 3 | 2022 | 27 | 0.610 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2025 | 35 | 0.610 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2019 | 5 | 0.580 |
Why?
|
| Fibroblasts | 1 | 2021 | 421 | 0.570 |
Why?
|
| Aggression | 1 | 2019 | 79 | 0.570 |
Why?
|
| Transcription Factors | 4 | 2022 | 1551 | 0.570 |
Why?
|
| Gene Expression Regulation | 6 | 2026 | 1629 | 0.570 |
Why?
|
| Depression | 3 | 2024 | 899 | 0.560 |
Why?
|
| Dopamine | 4 | 2025 | 108 | 0.540 |
Why?
|
| Brain Diseases | 1 | 2019 | 75 | 0.540 |
Why?
|
| Longevity | 1 | 2019 | 117 | 0.540 |
Why?
|
| Female | 27 | 2026 | 33917 | 0.520 |
Why?
|
| Vulnerable Populations | 1 | 2017 | 94 | 0.500 |
Why?
|
| Antipsychotic Agents | 4 | 2024 | 303 | 0.500 |
Why?
|
| beta-Endorphin | 2 | 2015 | 9 | 0.470 |
Why?
|
| Anxiety | 3 | 2020 | 424 | 0.470 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2015 | 19 | 0.440 |
Why?
|
| Dopaminergic Neurons | 4 | 2025 | 37 | 0.430 |
Why?
|
| Spleen | 2 | 2013 | 474 | 0.430 |
Why?
|
| Morphine | 2 | 2026 | 60 | 0.420 |
Why?
|
| Transcriptome | 7 | 2026 | 398 | 0.420 |
Why?
|
| Schizophrenia | 3 | 2022 | 275 | 0.420 |
Why?
|
| Humans | 32 | 2026 | 64935 | 0.420 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2015 | 122 | 0.410 |
Why?
|
| CLOCK Proteins | 4 | 2018 | 46 | 0.400 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2015 | 155 | 0.400 |
Why?
|
| Granzymes | 1 | 2013 | 22 | 0.390 |
Why?
|
| Perforin | 1 | 2013 | 26 | 0.390 |
Why?
|
| Disease Models, Animal | 6 | 2025 | 2282 | 0.370 |
Why?
|
| Proteome | 2 | 2023 | 151 | 0.370 |
Why?
|
| Psychotic Disorders | 2 | 2024 | 150 | 0.370 |
Why?
|
| Behavior | 1 | 2012 | 36 | 0.360 |
Why?
|
| Self Administration | 4 | 2026 | 49 | 0.350 |
Why?
|
| Mice, Inbred C3H | 1 | 2011 | 173 | 0.350 |
Why?
|
| Gene Expression Profiling | 4 | 2026 | 793 | 0.340 |
Why?
|
| Aging | 3 | 2025 | 763 | 0.340 |
Why?
|
| Rats | 7 | 2021 | 1989 | 0.330 |
Why?
|
| Interferon-gamma | 1 | 2013 | 574 | 0.330 |
Why?
|
| Sympathetic Nervous System | 1 | 2010 | 35 | 0.320 |
Why?
|
| Immune System | 1 | 2011 | 132 | 0.320 |
Why?
|
| Computational Biology | 1 | 2012 | 367 | 0.300 |
Why?
|
| Cocaine-Related Disorders | 2 | 2020 | 81 | 0.290 |
Why?
|
| Metabolic Diseases | 2 | 2021 | 59 | 0.280 |
Why?
|
| Biological Clocks | 3 | 2009 | 59 | 0.250 |
Why?
|
| Inflammation | 2 | 2025 | 1186 | 0.240 |
Why?
|
| Animals, Newborn | 2 | 2025 | 239 | 0.240 |
Why?
|
| Glutamic Acid | 3 | 2022 | 103 | 0.240 |
Why?
|
| Receptors, Serotonin, 5-HT4 | 1 | 2025 | 1 | 0.230 |
Why?
|
| Serotonin 5-HT4 Receptor Agonists | 1 | 2025 | 1 | 0.230 |
Why?
|
| Benzofurans | 1 | 2025 | 8 | 0.230 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 2 | 2025 | 4 | 0.230 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2025 | 38 | 0.230 |
Why?
|
| Extraembryonic Membranes | 1 | 2025 | 5 | 0.220 |
Why?
|
| Locomotion | 3 | 2021 | 110 | 0.220 |
Why?
|
| Mesencephalon | 1 | 2025 | 28 | 0.220 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 703 | 0.220 |
Why?
|
| Sequence Analysis, RNA | 3 | 2021 | 180 | 0.220 |
Why?
|
| Brain Mapping | 1 | 2026 | 240 | 0.220 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2025 | 90 | 0.220 |
Why?
|
| Behavior, Animal | 2 | 2018 | 234 | 0.220 |
Why?
|
| Mental Disorders | 1 | 2012 | 815 | 0.210 |
Why?
|
| Central Nervous System Depressants | 4 | 2015 | 46 | 0.200 |
Why?
|
| Premature Birth | 1 | 2025 | 114 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 731 | 0.190 |
Why?
|
| Suicidal Ideation | 1 | 2024 | 130 | 0.190 |
Why?
|
| Ketamine | 1 | 2023 | 39 | 0.190 |
Why?
|
| Macaca mulatta | 1 | 2024 | 260 | 0.190 |
Why?
|
| Periodicity | 1 | 2023 | 46 | 0.190 |
Why?
|
| Metformin | 1 | 2024 | 75 | 0.190 |
Why?
|
| Hyperalgesia | 1 | 2022 | 15 | 0.190 |
Why?
|
| Drug Tolerance | 1 | 2022 | 33 | 0.190 |
Why?
|
| Cytokines | 2 | 2021 | 951 | 0.180 |
Why?
|
| Arousal | 1 | 2022 | 42 | 0.180 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 361 | 0.180 |
Why?
|
| NAD | 2 | 2022 | 53 | 0.180 |
Why?
|
| Analgesics | 1 | 2022 | 102 | 0.180 |
Why?
|
| Ventral Tegmental Area | 2 | 2020 | 38 | 0.170 |
Why?
|
| Electroencephalography | 1 | 2022 | 149 | 0.170 |
Why?
|
| Buprenorphine | 1 | 2025 | 198 | 0.170 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2023 | 94 | 0.170 |
Why?
|
| Hypothalamus | 2 | 2012 | 133 | 0.170 |
Why?
|
| Vesicular Glutamate Transport Proteins | 1 | 2021 | 1 | 0.170 |
Why?
|
| Parkinsonian Disorders | 1 | 2021 | 15 | 0.170 |
Why?
|
| Eye Movements | 1 | 2022 | 86 | 0.170 |
Why?
|
| Astrocytes | 1 | 2022 | 123 | 0.170 |
Why?
|
| Glucagon | 1 | 2021 | 36 | 0.170 |
Why?
|
| Genetics | 1 | 2021 | 14 | 0.170 |
Why?
|
| Histone Deacetylase 2 | 1 | 2020 | 18 | 0.170 |
Why?
|
| Nerve Degeneration | 1 | 2021 | 68 | 0.170 |
Why?
|
| Models, Biological | 4 | 2017 | 1192 | 0.170 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 36 | 0.160 |
Why?
|
| Neurosciences | 1 | 2021 | 27 | 0.160 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 37 | 0.160 |
Why?
|
| Mutation | 3 | 2020 | 2657 | 0.160 |
Why?
|
| Insulin Resistance | 1 | 2023 | 414 | 0.160 |
Why?
|
| Insulin | 3 | 2023 | 695 | 0.160 |
Why?
|
| Species Specificity | 3 | 2020 | 339 | 0.160 |
Why?
|
| Molecular Biology | 1 | 2021 | 65 | 0.160 |
Why?
|
| Pregnancy Complications | 1 | 2025 | 384 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 542 | 0.160 |
Why?
|
| Blotting, Western | 2 | 2012 | 610 | 0.160 |
Why?
|
| Drinking | 2 | 2018 | 14 | 0.160 |
Why?
|
| Pain | 1 | 2022 | 398 | 0.150 |
Why?
|
| Software | 1 | 2023 | 394 | 0.150 |
Why?
|
| Social Behavior | 1 | 2019 | 85 | 0.150 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 180 | 0.150 |
Why?
|
| Conditioning, Operant | 1 | 2018 | 27 | 0.140 |
Why?
|
| Clozapine | 1 | 2018 | 32 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 765 | 0.140 |
Why?
|
| Receptors, Dopamine | 1 | 2017 | 16 | 0.140 |
Why?
|
| Genotype | 1 | 2020 | 673 | 0.130 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 152 | 0.130 |
Why?
|
| Lithium | 1 | 2017 | 22 | 0.130 |
Why?
|
| Synapses | 1 | 2019 | 193 | 0.130 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 325 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 869 | 0.120 |
Why?
|
| Norepinephrine | 2 | 2021 | 106 | 0.120 |
Why?
|
| Mood Disorders | 1 | 2016 | 78 | 0.120 |
Why?
|
| Fasting | 1 | 2015 | 52 | 0.120 |
Why?
|
| Dopamine Uptake Inhibitors | 3 | 2020 | 26 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 268 | 0.110 |
Why?
|
| Synaptic Transmission | 3 | 2022 | 151 | 0.110 |
Why?
|
| Drosophila Proteins | 1 | 2021 | 758 | 0.110 |
Why?
|
| Lithium Chloride | 1 | 2015 | 11 | 0.110 |
Why?
|
| Corticosterone | 1 | 2015 | 24 | 0.110 |
Why?
|
| Body Temperature | 1 | 2015 | 44 | 0.110 |
Why?
|
| Antimanic Agents | 1 | 2015 | 32 | 0.110 |
Why?
|
| Running | 1 | 2015 | 83 | 0.110 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2015 | 27 | 0.110 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 160 | 0.110 |
Why?
|
| Maze Learning | 1 | 2015 | 51 | 0.110 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2015 | 38 | 0.110 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 249 | 0.110 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 185 | 0.110 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 189 | 0.110 |
Why?
|
| Amygdala | 1 | 2015 | 85 | 0.110 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 2 | 0.110 |
Why?
|
| Restraint, Physical | 1 | 2015 | 58 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2025 | 1287 | 0.100 |
Why?
|
| Adolescent | 3 | 2024 | 6292 | 0.100 |
Why?
|
| Pregnancy | 2 | 2025 | 2372 | 0.100 |
Why?
|
| ARNTL Transcription Factors | 1 | 2013 | 25 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2015 | 497 | 0.100 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 302 | 0.090 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 56 | 0.090 |
Why?
|
| Photoperiod | 1 | 2012 | 30 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 907 | 0.090 |
Why?
|
| Work Schedule Tolerance | 1 | 2011 | 22 | 0.090 |
Why?
|
| Autonomic Nervous System | 1 | 2011 | 35 | 0.090 |
Why?
|
| Administration, Inhalation | 1 | 2011 | 159 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 211 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2011 | 294 | 0.080 |
Why?
|
| Sympathectomy, Chemical | 1 | 2010 | 1 | 0.080 |
Why?
|
| Guanethidine | 1 | 2010 | 3 | 0.080 |
Why?
|
| Sympatholytics | 1 | 2010 | 5 | 0.080 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 164 | 0.080 |
Why?
|
| Time Factors | 3 | 2015 | 3753 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 622 | 0.070 |
Why?
|
| Rats, Long-Evans | 2 | 2005 | 22 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 663 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2025 | 2187 | 0.060 |
Why?
|
| RNA | 1 | 2010 | 426 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2026 | 52 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2019 | 1138 | 0.060 |
Why?
|
| Cosmetics | 1 | 2005 | 16 | 0.060 |
Why?
|
| Terpenes | 1 | 2005 | 28 | 0.060 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2025 | 87 | 0.060 |
Why?
|
| Alcoholism | 2 | 2024 | 327 | 0.050 |
Why?
|
| Seizures | 1 | 2005 | 140 | 0.050 |
Why?
|
| Suicide, Attempted | 1 | 2024 | 111 | 0.050 |
Why?
|
| Adult | 4 | 2025 | 17307 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2025 | 323 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2025 | 350 | 0.050 |
Why?
|
| Fear | 1 | 2023 | 70 | 0.050 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2025 | 261 | 0.050 |
Why?
|
| Workflow | 1 | 2023 | 70 | 0.050 |
Why?
|
| Brain Stem | 1 | 2021 | 27 | 0.040 |
Why?
|
| Hippocampus | 1 | 2023 | 274 | 0.040 |
Why?
|
| Rotenone | 1 | 2021 | 6 | 0.040 |
Why?
|
| Rats, Inbred Lew | 1 | 2021 | 106 | 0.040 |
Why?
|
| Adrenergic Agents | 1 | 2021 | 15 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2025 | 348 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 5600 | 0.040 |
Why?
|
| Glucose | 1 | 2024 | 476 | 0.040 |
Why?
|
| Insecticides | 1 | 2021 | 45 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2020 | 71 | 0.040 |
Why?
|
| Rodentia | 1 | 2020 | 20 | 0.040 |
Why?
|
| Synaptic Vesicles | 1 | 2020 | 25 | 0.040 |
Why?
|
| Pancreas | 1 | 2021 | 154 | 0.040 |
Why?
|
| Anhedonia | 1 | 2020 | 9 | 0.040 |
Why?
|
| Gonadal Hormones | 1 | 2020 | 5 | 0.040 |
Why?
|
| Light | 2 | 2015 | 195 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2020 | 59 | 0.040 |
Why?
|
| Biological Transport | 1 | 2020 | 292 | 0.040 |
Why?
|
| Nerve Net | 1 | 2020 | 100 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2020 | 86 | 0.040 |
Why?
|
| Cell Survival | 1 | 2021 | 587 | 0.040 |
Why?
|
| Behavior, Addictive | 1 | 2020 | 75 | 0.040 |
Why?
|
| Affect | 1 | 2020 | 128 | 0.040 |
Why?
|
| Middle Aged | 3 | 2025 | 18203 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2025 | 1576 | 0.040 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2018 | 1 | 0.040 |
Why?
|
| Receptor, Muscarinic M4 | 1 | 2018 | 2 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2018 | 37 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2018 | 64 | 0.030 |
Why?
|
| Action Potentials | 1 | 2018 | 113 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2018 | 130 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 213 | 0.030 |
Why?
|
| Drosophila | 1 | 2021 | 480 | 0.030 |
Why?
|
| Neuroglia | 1 | 2018 | 81 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 2017 | 76 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 2701 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2021 | 1414 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2018 | 754 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 156 | 0.030 |
Why?
|
| Physical Conditioning, Animal | 1 | 2015 | 43 | 0.030 |
Why?
|
| Proteomics | 1 | 2017 | 292 | 0.030 |
Why?
|
| Aged | 2 | 2025 | 14917 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 297 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 852 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 2152 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 581 | 0.030 |
Why?
|
| Genome, Human | 1 | 2015 | 237 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 460 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 2612 | 0.020 |
Why?
|
| Algorithms | 1 | 2018 | 1039 | 0.020 |
Why?
|
| alpha-MSH | 1 | 2012 | 3 | 0.020 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2012 | 7 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2012 | 14 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2012 | 34 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 70 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2018 | 917 | 0.020 |
Why?
|
| United States | 1 | 2024 | 8082 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 602 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 1580 | 0.020 |
Why?
|
| Triazolam | 1 | 2007 | 4 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 2007 | 18 | 0.020 |
Why?
|
| Mesocricetus | 1 | 2007 | 92 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2007 | 159 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2007 | 89 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2007 | 66 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2007 | 75 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 362 | 0.020 |
Why?
|
| Camphor | 1 | 2005 | 1 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 4793 | 0.010 |
Why?
|
| Activity Cycles | 1 | 2005 | 2 | 0.010 |
Why?
|
| Chronobiology Phenomena | 1 | 2005 | 2 | 0.010 |
Why?
|
| Intellectual Disability | 1 | 2005 | 176 | 0.010 |
Why?
|
| Infant | 1 | 2005 | 1683 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2005 | 2052 | 0.010 |
Why?
|